CONTRAFECT Corp 3 SEC Filings

Filed On	Filing
11 Feb 2021	Form 3: Barlow Jane F, Director No securities owned
17 Jun 2020	Form 3: Aklog Lishan, Director No securities owned
18 Aug 2017	Form 3: Shanghai Fosun Pharmaceutical (Group) Co., Ltd., 10% owner Holds 8,500,000 shares of Common Stock
18 Aug 2017	Form 3: Fosun Industrial Co., Ltd, 10% owner Holds 8,500,000 shares of Common Stock
17 Feb 2017	Form 3: Ricciardi Lisa, Director
04 Nov 2015	Form 3: Muntner Joshua B, SVP Business Development No securities owned
04 Nov 2015	Form 3: Cassino Cara M, Chief Medical Officer No securities owned
20 May 2015	Form 3: Gilman Steven C, Director
06 May 2015	Form 3: Tian Lawrence Yuan, Director
09 Dec 2014	Form 3: Ernest W Moody Revocable Trust, 10% owner Holds 1,000,000 shares of common stock
05 Dec 2014	Form 3: Bogdanos Natalie, General Counsel
29 Jul 2014	Form 3: Sucoff Cary, Director
29 Jul 2014	Form 3: Zan Shengda, Director Holds 1,337,036 shares of Common Stock, par value $0.0001 per share
29 Jul 2014	Form 3: Messinger Michael, VP Finance
29 Jul 2014	Form 3: Couto Daniel, SVP Manufacturing & Facilities
29 Jul 2014	Form 3: Dong Nancy, VP Controller Holds 8,874 shares of Common Stock, par value $0.0001 per share
29 Jul 2014	Form 3: Huang David B., Chief Medical Officer Holds 83,568 shares of Common Stock, par value $0.0001 per share
29 Jul 2014	Form 3: Kappel Barry J., SVP Business Development
29 Jul 2014	Form 3: Otto Michael J., Director
29 Jul 2014	Form 3: Wittekind Michael G., Chief Scientific Officer

Comments